AAAAAA

   
Results: 1-9 |
Results: 9
Reducing community dyspepsia drug costs: a controlled trial
Authors: Valori, RM Brown, CM Strangeways, P Bradburn, M
Citation: Rm. Valori et al., Reducing community dyspepsia drug costs: a controlled trial, GUT, 49(4), 2001, pp. 495-501
Overexpression of H-Ryk in epithelial ovarian cancer: Prognostic significance of receptor expression
Authors: Katso, RMT Manek, S Ganjavi, H Biddolph, S Charnock, MFL Bradburn, M Wells, M Ganesan, TS
Citation: Rmt. Katso et al., Overexpression of H-Ryk in epithelial ovarian cancer: Prognostic significance of receptor expression, CLIN CANC R, 6(8), 2000, pp. 3271-3281
Treatment of mantle-cell lymphoma with Rituximab (chimeric monoclonal anti-CD20 antibody): Analysis of factors associated with response
Authors: Foran, JM Cunningham, D Coiffier, B Solal-Celigny, P Reyes, F Ghielmini, M Johnson, PWM Gisselbrecht, C Bradburn, M Matthews, J Lister, TA
Citation: Jm. Foran et al., Treatment of mantle-cell lymphoma with Rituximab (chimeric monoclonal anti-CD20 antibody): Analysis of factors associated with response, ANN ONCOL, 11, 2000, pp. 117-121
High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: Long-term clinical and molecular follow-up
Authors: Apostolidis, J Gupta, RK Grenzelias, D Johnson, PWM Pappa, VI Summers, KE Salam, A Adams, K Norton, AJ Amess, JAL Matthews, J Bradburn, M Lister, TA Rohatiner, AZS
Citation: J. Apostolidis et al., High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: Long-term clinical and molecular follow-up, J CL ONCOL, 18(3), 2000, pp. 527-536
Prevention of worsening of severe thrombocytopenia after red cell transfusions by the use of leucocyte-depleted blood
Authors: Schuh, A Atoyebi, W Littlewood, T Hatton, C Bradburn, M Murphy, MF
Citation: A. Schuh et al., Prevention of worsening of severe thrombocytopenia after red cell transfusions by the use of leucocyte-depleted blood, BR J HAEM, 108(2), 2000, pp. 455-457
Teaching non-specialist health care professionals how to identify the atypical mole syndrome phenotype: a multinational study
Authors: Bishop, JAN Bradburn, M Bergman, W Osterlind, A Pinney, E Rosdahl, I Scerri, L Weichenthal, M Mant, D Breitbart, EW Karlsson, P Altman, DG
Citation: Jan. Bishop et al., Teaching non-specialist health care professionals how to identify the atypical mole syndrome phenotype: a multinational study, BR J DERM, 142(2), 2000, pp. 331-337
Randomised trials useful to find best methods of enhancing clinical practice
Authors: Wyatt, JC Paterson-Brown, S Fisk, NM Johnson, R Altman, DG Bradburn, M
Citation: Jc. Wyatt et al., Randomised trials useful to find best methods of enhancing clinical practice, BR MED J, 318(7194), 1999, pp. 1353-1353
Immunocytoma: A retrospective analysis from St Bartholomew's Hospital - 1972 to 1996
Authors: Papamichael, D Norton, AJ Foran, JM Mulatero, C Mathews, J Amess, JAL Bradburn, M Lister, TA Rohatiner, AZS
Citation: D. Papamichael et al., Immunocytoma: A retrospective analysis from St Bartholomew's Hospital - 1972 to 1996, J CL ONCOL, 17(9), 1999, pp. 2847-2853
Patterns of outcome following recurrence after myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma
Authors: Apostolidis, J Foran, JM Johnson, PWM Norton, A Amess, J Matthews, J Bradburn, M Lister, TA Rohatiner, AZS
Citation: J. Apostolidis et al., Patterns of outcome following recurrence after myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma, J CL ONCOL, 17(1), 1999, pp. 216-221
Risultati: 1-9 |